{"version":"1.0","type":"rich","title":"CliniMACS + G-CSF + HPC,A Infusion + RITUXIMAB + BLINATUMOMAB + Cyclophosphamide + THIOTEPA + LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN + Mesna + FLUDARABINE + Melphalan + Sirolimus + Tacrolimus for myelodysplastic syndromes","provider_name":"What came of it?","provider_url":"https://staging.whatcameofit.com/","html":"<iframe src=\"https://staging.whatcameofit.com/embed/clinimacs-g-csf-hpc-a-infusion-rituximab-blinatumomab-cyclophosphamide-thiotepa-lapine-t-lymphocyte-immune-globulin-mesna-fludarabine-melphalan-sirolimus-tacrolimus--myelodysplastic-syndromes\" title=\"CliniMACS + G-CSF + HPC,A Infusion + RITUXIMAB + BLINATUMOMAB + Cyclophosphamide + THIOTEPA + LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN + Mesna + FLUDARABINE + Melphalan + Sirolimus + Tacrolimus for myelodysplastic syndromes\" width=\"440\" height=\"420\" style=\"border:0;max-width:100%\" loading=\"lazy\"></iframe>","width":440,"height":420,"thumbnail_url":"https://staging.whatcameofit.com/brand-card.png?v=b7e2e5c93907","thumbnail_width":1200,"thumbnail_height":630,"cache_age":86400}